A groundbreaking shift in our drug policy has occurred, as the regulators allow the use of psilocybin hallucinogens for therapeutic treatment. Previously, these substances were heavily restricted, but a mounting body of research suggests they potentially offer relief for emotional conditions like anxiety. The new policy represents a key step toward